Find trials
Search tips

EEG sensing headband for improving long Covid sleep disorder in the Treatment of Post Covid Symptoms

Overview

About this study

The purpose of this study will be looking at patients diagnosed with post-COVID, continue to experience symptoms and report experiencing sleep issues.  Each study participant will receive a Brain Activity Sensing Headband system with an APP, wearable activity tracking device, and earbuds to participate in the study to complete study activies.  Study participation lasts approximately 6 weeks involving wearing the headband system in the evenings before bed for a minumum of 10 minutes, participating in 4 weeks of sleep meditation before bed with the system, and wear the activity tracking device to track sleep.  The earbuds may be used with participation in the meditations.  Participants will also be asked to complete sets of surveys during study participation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • 18 years of age or older at time of consent.
  • Identified with LC and reporting sleep issues at Mayo Clinic Rochester:
  • Not pregnant by subject self-report at time of consent.
  • Have the ability to provide informed consent.
  • Have the ability to complete all aspects of this trial.
  • Have access to an iPhone, iPad, or Android device and willingness to use for the research study.
  • Have the ability to be able to use the MUSE headband wearable and related ear pods at night to assist in sleeping.
  • Ability to participate in all aspects of the study.
  • Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-S™ system, as determined by the clinical investigators.

Exclusion Criteria: 

  • Used an investigational drug within the past 30 days.
  • Anyone who is on a medication for anxiety, depression or sleep and not on a stable dose for a minimum of 3 months.
  • Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.
  • Currently (within 3 weeks) has been enrolled in another clinical or research program which intervenes on the patients’ QOL, stress, or sleep.
  • An unstable medical or mental health condition as determined by the physician investigator.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/07/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ryan Hurt, M.D., Ph.D.

Contact us for the latest status

Contact information:

Shawn Fokken CCRP

(507) 293-2740

GIMresearchstudies@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20582690

Mayo Clinic Footer